RECITALS:Contingent Value Right Agreement • April 7th, 1998 • Fac Realty Trust Inc • Real estate investment trusts • New York
CONTINGENT VALUE RIGHT AGREEMENTContingent Value Right Agreement • October 23rd, 2024 • Lumos Pharma, Inc. • Pharmaceutical preparations • Delaware
This Contingent Value Right Agreement, dated as of [●], 2024 (this “Agreement”), is entered into by and DPV Parent, Inc., a Delaware corporation (“Parent”), and [RIGHTS AGENT], a [●], as Rights Agent (the “Rights Agent”).
CONTINGENT VALUE RIGHT AGREEMENTContingent Value Right Agreement • June 5th, 2024 • New York
This Contingent Value Right Agreement (this “CVR Agreement”), is entered into as of November 14, 2023, between Mallinckrodt plc, a public limited company incorporated in Ireland having registered number 522227 (the “Company”) and Opioid Master Disbursement Trust II, the master disbursement trust referred to in the Plan as MDT II (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 22.
CONTINGENT VALUE RIGHT AGREEMENTContingent Value Right Agreement • April 5th, 2001 • Primacom Ag • Cable & other pay television services • New York
CONTINGENT VALUE RIGHT AGREEMENT BETWEEN MALLINCKRODT PLC, AND OPIOID MASTER DISBURSEMENT TRUST II November 14, 2023Contingent Value Right Agreement • November 15th, 2023 • Mallinckrodt PLC • Pharmaceutical preparations • New York
This Contingent Value Right Agreement (this “CVR Agreement”), is entered into as of November 14, 2023, between Mallinckrodt plc, a public limited company incorporated in Ireland having registered number 522227 (the “Company”) and Opioid Master Disbursement Trust II, the master disbursement trust referred to in the Plan as MDT II (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 22.
CONTINGENT VALUE RIGHT AGREEMENTContingent Value Right Agreement • November 19th, 2021 • Pacira BioSciences, Inc. • Pharmaceutical preparations • Delaware
This Contingent Value Right Agreement, dated as of November 19, 2021 (this “Agreement”), is entered into by and between Pacira BioSciences, Inc., a Delaware corporation (“Parent”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company, as Rights Agent (the “Rights Agent”).
